Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,017,493
+$3,042,796 QoQ
Shares Held
87,496
+0.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#580
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisors Asset Management, Inc. holds $248,035,659 across 15 Drug Manufacturers - General names. ABBV ranks #5 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
346,193 | $44,485,800 | |
| 2 | AMGN |
Amgen Inc
|
97,240 | $35,212,548 | |
| 3 | JNJ |
Johnson & Johnson
|
137,584 | $34,942,208 | |
| 4 | LLY |
ELI LILLY & Co
|
22,773 | $27,314,621 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
87,496 | $22,017,493 | |
| 6 | PFE |
Pfizer Inc
|
873,428 | $21,032,146 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
302,317 | $17,419,505 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
127,450 | $16,102,033 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,017,493 | 87,496 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,974,697 | 87,244 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,364,198 | 80,372 | Shares | Sole | 2026-08-21 | |
| 2025-09-30 | $16,690,792 | 72,086 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $13,752,771 | 74,091 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $16,118,583 | 76,931 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $17,646,320 | 99,304 | Shares | Sole | 2026-08-21 | |
| 2024-09-30 | $27,666,553 | 140,098 | Shares | Sole | 2026-08-21 | |
| 2024-06-30 | $30,726,435 | 179,142 | Shares | Sole | 2026-08-21 | |
| 2024-03-31 | $39,555,579 | 217,219 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $39,283,810 | 253,493 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $41,584,013 | 278,975 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $38,591,926 | 286,439 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $47,530,190 | 298,238 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $47,461,139 | 293,677 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $39,967,201 | 297,796 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $45,934,062 | 299,909 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $50,785,010 | 313,275 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $43,552,628 | 321,659 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $33,501,078 | 310,569 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $32,418,355 | 287,805 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $28,787,710 | 266,011 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $25,206,930 | 235,249 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $19,092,955 | 217,981 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $21,911,026 | 223,172 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $17,606,975 | 231,093 | Shares | Sole | 2026-08-21 | |
| No filing history on record for this holder in this stock. | ||||||